|

RC1416 Placebo Clinical Trials

2 actively recruiting trials

▲ +1 trial since August 2026

Pipeline

Phase 2: 2

Top Sponsors

  • Nanjing RegeneCore Biotech Co., Ltd.2

Indications

  • Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)1
  • Moderate to Severe Asthma1
  • Asthma1
  • COPD1

Other2 trials

Phase II Study of RC1416 Injection in COPD
Phase 2
Phase II Trial of RC1416 Injection in Asthma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.